1The paradigm shift in the diagnosis of Alzheimer's diseaseJI Yong, WANG PanSpecial Topic105-1082New era in Alzheimer's disease therapeutics:transitioning from symptomatic management to disease-modifying paradigmsCHEN Xiao-chun, LIAO Jiang-fengSpecial Topic109-1113Consensus on diagnostic criteria for Alzheimer's diseaseCongress of Neuro-Degenerative Diseases Committee of Chinese Society of Microcirculation, LI Yan-feng, JI YongStandard and Guidelines112-1284Expert consensus on the selection of accessory examinations for cognitive dysfunction disorders based on the biomarker diagnostic frameworkNeurodegenerative Disease Special Committee,China Association for Promotion of Health Science and Technology, Shandong Provincial Key Laboratory of Neuroimmune Interaction and Regulation, BA Mao-wen, WANG Xi-jinStandard and Guidelines129-1435Interpretation of"Specification for interdisciplinary team service of the elderly with cognitive impairment"LI Wen-jie, SONG Yue-tao, LÜ Ji-huiStandard and Guidelines144-1516Comparison between the MIND-China study and similar international large-scale cohort studiesWANG Xiao-yu, DU Yi-fengChina Alzheimer's Disease Cohort Study152-1607Progress on the pathogenesis of Alzheimer's diseaseWANG Pu-yun, WANG Cai-xia, JIA Yan-hong, SUN Yong-jie, LIU Mei-li, LIANG Fu-ruDementia-associated Cognitive Impairment161-1688Progress on frontotemporal dementiaXU Yu-xuan, NAN Hai-tian, CHU Min, WU Li-yongDementia-associated Cognitive Impairment169-1789Advance in the clinical diagnosis and treatment of Alzheimer's diseaseLIAO Jiang-feng, CHEN Xiao-chunDementia-associated Cognitive Impairment179-18710Advance in Lecanemab therapy for Alzheimer's diseaseQIANG Qi-qi, LIU Pei-jie, CUI Si-meng, QU Qiu-minDementia-associated Cognitive Impairment188-19311Multimodal cognitive rehabilitation interventions for cognitive dysfunction disordersGAO Lu, BI Min, JIANG Bin, WANG Jing, NI Guo-xin, ZHENG Kun-muDementia-associated Cognitive Impairment194-202